In hyperlipidemia model, IOP‐A2 hypolipidemic role seems to occur mainly by promoting cholesterol metabolism and regulating the expression of the cholesterol metabolism‐related proteins CYP7A1, LXRα, SR‐B1, and ABCA1. Here, SCARB1 is linked to hyperlipidemia.